COVALON TECHNOLOGIES NEW Aktie

Covalon reported Q3 fiscal 2026 revenue of CAD 10.0m (+20% y/y), net income of CAD 2.8m (prior year CAD 65,000) and adjusted EBITDA of CAD 3.0m. Gross margin rose to 67.2% from 46.5% a year earlier, driving a strong margin expansion and substantially higher gross profit. Management attributes the improvement to stronger U.S. demand, particularly for contamination-protection products (growth ~51%), and to operational scale effects, viewing the quarter as part of a multi-year strategy. The stock traded only slightly lower and remains near its 52-week high; the company remains a small-cap with further growth potential. » More on de.investing.com

Covalon Technologies posted revenue of CAD 8.7 million in the second quarter of 2026 (+14.5% year‑over‑year) and diluted EPS of CAD 0.04, which doubled versus the year‑ago quarter. Gross margin rose to 61.5% (previously 54.5%) and adjusted EBITDA climbed to CAD 1.3 million (+127%). Operating expenses increased 15% due to regulatory and testing costs, which could weigh on future profitability. For fiscal 2027 the company expects negative EPS development but continues to focus on growth in U.S. and international markets as well as investments in automation and efficiency. » More on de.investing.com

Covalon Technologies recorded revenue of $8.7m in Q4 2025 (unchanged year‑on‑year) and its seventh consecutive profitable quarter. For the fiscal year, revenue rose 5% to $32.8m; gross margin was 53% (56% adjusted). The company announced its first special dividend of CAD 0.15 per share, holds CAD 17m in liquidity and plans to drive growth through US market expansion, sales and partnerships. » More on de.investing.com